Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer—a valid option for cisplatin-unfit patients?

PURPOSE: Treatment of muscle-invasive bladder cancer (MIBC) remains challenging, especially for elderly and/or comorbid patients. Patients who are unfit for or refuse surgery should receive bladder-preserving multimodality treatment (BPMT), consisting of transurethral resection of the bladder tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, C. R., Lindner, A. K., Schachtner, G., Tulchiner, G., Tulchiner, N., Mangesius, J., Maffei, M., Horninger, W., Kouvaiou, O., Lukas, P., Ganswindt, U., Pichler, R., Skvortsov, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760228/
https://www.ncbi.nlm.nih.gov/pubmed/34414475
http://dx.doi.org/10.1007/s00066-021-01837-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760228/
https://www.ncbi.nlm.nih.gov/pubmed/34414475
http://dx.doi.org/10.1007/s00066-021-01837-7

Ejemplares similares